Can Hims & Hers Stock Find Its Footing?

The telehealth sector presents a study in contrasts, and Hims & Hers Health, Inc. is a prime example. While the company’s underlying business demonstrates remarkable strength, its share price tells a different, more troubled story. A recent strategic move by management—a substantial share repurchase authorization—has investors questioning whether this could be the catalyst that finally stabilizes the equity.

Fundamentally, Hims & Hers continues to execute impressively. The company’s third-quarter 2025 financial results revealed a powerful 49% year-over-year revenue surge, reaching approximately $599 million. This robust growth rate underscores a rapidly expanding customer base and sustained high demand for digital health solutions.

Despite these solid operational Read more...